ResearcherStavanger University HospitalActive in the last 2 years
Morten Lapin
Matched on ORCID iD 0000-0003-4183-0679; OpenAlex author ID A5032117291. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 1 paper
Papers 7
- Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragm… Co-author DOI 10.1002/1878-0261.70116↗
- Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiol… Co-author DOI 10.1002/1878-0261.13472↗
- Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-22-3526↗
- Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. Co-author DOI 10.1371/journal.pone.0291623↗
- Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study. First author DOI 10.1186/s12885-022-09714-x↗
- Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. Co-author DOI 10.1186/s12967-018-1677-2↗
- Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. First author DOI 10.1016/j.molonc.2015.11.012↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kjersti Tjensvoll · 7 shared papers, 2016–2025 · strength 1.09
- Paper Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methyl… DOI 10.1002/1878-0261.70116↗
- Paper Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. DOI 10.1371/journal.pone.0291623↗
- Paper Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals… DOI 10.1002/1878-0261.13472↗
- Bjørnar Gilje · 7 shared papers, 2016–2025 · strength 1.09
- Paper Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methyl… DOI 10.1002/1878-0261.70116↗
- Paper Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. DOI 10.1371/journal.pone.0291623↗
- Paper Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals… DOI 10.1002/1878-0261.13472↗
- Oddmund Nordgård · 7 shared papers, 2016–2025 · strength 1.09
- Paper Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methyl… DOI 10.1002/1878-0261.70116↗
- Paper Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. DOI 10.1371/journal.pone.0291623↗
- Paper Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals… DOI 10.1002/1878-0261.13472↗
- Karin Hestnes Edland · 4 shared papers, 2022–2025 · strength 0.75
- Paper Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methyl… DOI 10.1002/1878-0261.70116↗
- Paper Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals… DOI 10.1002/1878-0261.13472↗
- Paper Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progres… DOI 10.1158/1078-0432.ccr-22-3526↗
- Rune Smaaland · 3 shared papers, 2016–2022 · strength 0.28
- Paper Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observatio… DOI 10.1186/s12885-022-09714-x↗
- Paper Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. DOI 10.1186/s12967-018-1677-2↗
- Paper Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. DOI 10.1016/j.molonc.2015.11.012↗
- Milind M. Javle · 2 shared papers, 2016–2018 · strength 0.13
- Paper Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. DOI 10.1186/s12967-018-1677-2↗
- Paper Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. DOI 10.1016/j.molonc.2015.11.012↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.